Regulatory T cells: the future of autoimmune disease treatment
- 27 May 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 15 (7) , 777-789
Abstract
Introduction: CD4+ T regulatory cells (Tregs) have been described as the most potent immunosuppressive cells in the human body. They have been found to control autoimmunity, and clinical attempts have been made to apply them to treat autoimmune diseases. Some specific pathways utilized by Tregs in the regulation of immune response or Tregs directly as cellular products are tested in the clinic. Areas covered: Here, we present recent advances in the research on the biology and clinical applications of Tregs in the treatment of autoimmune diseases. Expert opinion: Regulatory T cells seem to be a promising tool for the treatment of autoimmune diseases. The development of both cell-based therapies and modern pharmacotherapies which affect Tregs may strongly improve the treatment of autoimmune disorders. Growing knowledge about Treg biology together with the latest biotechnology tools may give an opportunity for personalized therapies in these conditions.Keywords
This publication has 178 references indexed in Scilit:
- Pregnancy imprints regulatory memory that sustains anergy to fetal antigenNature, 2012
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’Nature, 2012
- Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactionsNature Medicine, 2011
- Foxp3+ follicular regulatory T cells control the germinal center responseNature Medicine, 2011
- Characterization of Interleukin-17–Producing Regulatory T Cells in Inflamed Intestinal Mucosa From Patients With Inflammatory Bowel DiseasesGastroenterology, 2011
- Induction of transplantation tolerance converts potential effector T cells into graft‐protective regulatory T cellsEuropean Journal of Immunology, 2010
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- Transient regulatory T-cells: A state attained by all activated human T-cellsClinical Immunology, 2007
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritisEuropean Journal of Immunology, 2003